Truist analyst Richard Newitter raised the firm’s price target on Integer (ITGR) to $150 from $140 and keeps a Buy rating on the shares. The company reported a Q1 beat on organic revenue and strength in Cardio & Vascular business, and the firm continues to believe that Integer can profitably grow above its end market, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITGR:
- Positive Outlook for Integer Holdings: Strong Q1 Performance, Strategic Debt Refinancing, and Smooth CEO Transition Support Buy Rating
- Integer Holdings’ Earnings Call Highlights Robust Growth
- Integer price target raised to $150 from $140 at Truist
- Integer price target raised to $150 from $145 at Raymond James
- Integer price target lowered to $140 from $150 at Benchmark